Nick Tate
Nick Tate Senior Editorial Manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.
Nick Tate is the senior editorial manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.
As a best-selling author, seasoned journalist and TV commentator specializing in health care, finance and biotech, Nick is all about big ideas and innovations — always keeping his followers informed on the next big thing.
His work has appeared in The Miami Herald, The Atlanta Journal-Constitution, South Florida Business Journal, Newsmax Magazine, South Florida Sun Sentinel, Boston Herald, and on Newsmax TV and the Al Jazeera network.
His top-selling book, the ObamaCare Survival Guide, was on the Publishers Weekly and The New York Times best-sellers lists for 22 weeks — reaching No. 1 on The Times list for paperback advice books.
Tate also co-authored DaVinci’s Baby Boomer Survival Guide: Live, Prosper, and Thrive in Your Retirement. And he published two other books — the Encyclopedia of Natural Healing and The Sick Building Syndrome — following a year-long journalism fellowship at the Harvard School of Public Health.
Tate’s three-decades-long commitment to keeping the public well-informed is why Banyan Hill Publishing recruited him in 2018 to join Paul Mampilly’s team. You can now read Nick’s weekly analysis in Bold Profits Daily as he guides over 130,000 readers on the best ways to grow their wealth.
Nick Tate's Articles
New Precision Medicine RX = Next-Level Gains June 10, 2021 Bold Profits Daily, Stocks, Trading Strategies
- This new precision medicine therapy points to incredible investment potential. Here’s your best play for “next-level” profits.
3D Printing Solves This $1.5 Trillion Problem: Invest Today May 20, 2021 Bold Profits Daily, Investment Opportunities, Technology
- Problem: Prescriptions are expensive and don’t always work. Solution: 3D printing. Here’s a double play for 3D printing plus precision medicine.
AI + Precision Medicine = 1-2 Punch for America 2.0 Profits April 29, 2021 Bold Profits Daily, Investment Opportunities, Technology
- Artificial intelligence and precision medicine are teaming up for a one-two punch that is reshaping America 2.0 health care — offering HUGE investment potential.
Get the Next Biotech Takeover Trade Today April 15, 2021 Bold Profits Daily, Investment Opportunities, Stocks
- America 2.0 biotech companies are reshaping our health care system. Here’s how to buy in before new mega trend medical marvels take the sector to new highs. 
Buy Into Precision Medicine’s “Digital New Deal” Boost April 8, 2021 Bold Profits Daily, Investment Opportunities, Stocks
- The Digital New Deal contains billions to fund tech innovations in precision medicine. Here’s the top way to buy in before it skyrockets.
1 ETF to Buy Before Next 547% Gain in Genetics Testing March 18, 2021 Bold Profits Daily, Investment Opportunities, Technology
- When the price for an in-demand tech product drops this much it’s the trigger for phenomenal gains.
First 3D-Printed Burger: No. 1 Way to Profit February 25, 2021 Bold Profits Daily, Investment Opportunities, Technology
- It's the world’s first 3D-printed burger — pushing the technology into the mainstream and helping boost early investors’ profits.
3D-Printed Hearts = Your Path to 5X Profits February 4, 2021 Bold Profits Daily, Investment Opportunities, Stocks
- Make sure you’re in front of this new 3D printing breakthrough before the next 5X move.
2 Best ETFs for Precision Medicine’s “Breakout” Year January 14, 2021 Bold Profits Daily, Investment Opportunities, Stocks
- 2021 will be a breakout year for precision medicine. Here are two massive precision medicine ETFs you can buy today to get ready for the big gains ahead. 
1 Sell Before $3.6 Trillion Precision Medicine Disruption December 17, 2020 Bold Profits Daily, Investment Opportunities, Stocks
- Here’s one old-world medicine sell and one precision medicine buy for your 2021 portfolio … before our nation’s $3.6 trillion health care disruption.
